Kareem Saad
Corporate Officer/Principal bei GENEDX HOLDINGS CORP.
Vermögen: 329 705 $ am 30.04.2024
Profil
Kareem M.
Saad is currently the Chief Transformation Officer at GeneDx Holdings Corp.
He previously held positions as President & Chief Executive Officer at HealthCare IT, Inc. and Gulfstream Group LLC.
From 2009 to 2013, he served as the National Sales Director at Dell Technologies, Inc. He also worked as the Vice President-Marketing & Business Development at Codon Devices, Inc. In 2020 to 2021, he was the President & Chief Operating Officer at Apervita, Inc. From 2015 to 2017, he served as the Chief Commercial Officer at Source Medical Solutions, Inc. Additionally, he held the position of Chief Strategy Officer at Mount Sinai Genomics, Inc. Mr. Saad holds an MBA from The University of Chicago and an undergraduate degree from the University of British Columbia.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 15.04.2024 | 29 517 ( 0,11% ) | 329 705 $ | 30.04.2024 |
Aktive Positionen von Kareem Saad
| Unternehmen | Position | Beginn |
|---|---|---|
| GENEDX HOLDINGS CORP. | Corporate Officer/Principal | 22.07.2021 |
Ehemalige bekannte Positionen von Kareem Saad
| Unternehmen | Position | Ende |
|---|---|---|
Apervita, Inc.
 Apervita, Inc. Packaged SoftwareTechnology Services Apervita, Inc. operates a health analytics marketplace. It enables providers, payers and stakeholders to connect, build and share critical applications that improve consumer and clinician experience, and healthcare outcomes. The company was founded by Paul J. Magelli Jr., Brad Ryan and Geoffrey Phillips in 2012 and is headquartered in Chicago, IL. | Präsident | 01.01.2021 |
Source Medical Solutions, Inc.
 Source Medical Solutions, Inc. Packaged SoftwareTechnology Services Source Medical Solutions, Inc. develops healthcare management systems. Its solutions include software, analytics, revenue cycle, and professional services. The company was founded in 2000 and is headquartered in Birmingham, AL. | Corporate Officer/Principal | 01.06.2017 |
| DELL TECHNOLOGIES INC. | Vertrieb & Marketing | 01.07.2013 |
Codon Devices, Inc.
 Codon Devices, Inc. Pharmaceuticals: MajorHealth Technology Codon Devices, Inc. produces pharmaceuticals and biorefineries for the production of industrial chemicals and bio-energy. The firm designs and constructs biological components such as enzymes, biopharmaceuticals, and cell lines for improved function. Its customers include the biotechnology, pharmaceutical, and agriculture sectors. The company was founded by Noubar B. Afeyan, George Church, Drew Endy, Joseph M. Jacobson and Jay Keasling in 2004 and is headquartered in Cambridge, MA. | Vertrieb & Marketing | 05.01.2010 |
Mount Sinai Genomics, Inc.
 Mount Sinai Genomics, Inc. Medical/Nursing ServicesHealth Services Mount Sinai Genomics, Inc. operates online predictive health analysis platform for diagnosis, treatment and prevention of diseases. It offers Centrellis which analyzes and interprets extensive information about known inherited diseases, including related mutations, frequency across populations, and the penetrance and expressivity of genetic changes. The company was founded by Eric Schadt and is headquartered in Stamford, CT. | Corporate Officer/Principal | - |
Ausbildung von Kareem Saad
| The University of Chicago | Masters Business Admin |
| University of British Columbia | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| DELL TECHNOLOGIES INC. | Electronic Technology |
| GENEDX HOLDINGS CORP. | Health Services |
| Private Unternehmen | 6 |
|---|---|
Codon Devices, Inc.
Codon Devices, Inc. Pharmaceuticals: MajorHealth Technology Codon Devices, Inc. produces pharmaceuticals and biorefineries for the production of industrial chemicals and bio-energy. The firm designs and constructs biological components such as enzymes, biopharmaceuticals, and cell lines for improved function. Its customers include the biotechnology, pharmaceutical, and agriculture sectors. The company was founded by Noubar B. Afeyan, George Church, Drew Endy, Joseph M. Jacobson and Jay Keasling in 2004 and is headquartered in Cambridge, MA. | Health Technology |
Apervita, Inc.
Apervita, Inc. Packaged SoftwareTechnology Services Apervita, Inc. operates a health analytics marketplace. It enables providers, payers and stakeholders to connect, build and share critical applications that improve consumer and clinician experience, and healthcare outcomes. The company was founded by Paul J. Magelli Jr., Brad Ryan and Geoffrey Phillips in 2012 and is headquartered in Chicago, IL. | Technology Services |
Source Medical Solutions, Inc.
Source Medical Solutions, Inc. Packaged SoftwareTechnology Services Source Medical Solutions, Inc. develops healthcare management systems. Its solutions include software, analytics, revenue cycle, and professional services. The company was founded in 2000 and is headquartered in Birmingham, AL. | Technology Services |
HealthCare IT, Inc.
 HealthCare IT, Inc. Information Technology ServicesTechnology Services HealthCare IT, Inc. provides biomedical research software and healthcare managed hosting services. The company is headquartered in Columbia, MD. | Technology Services |
Gulfstream Group LLC
 Gulfstream Group LLC Investment ManagersFinance Gulfstream group LLC (Gulfstream group) is a private equity firm founded in 2002. The firm is headquartered in Lexington, Massachusetts. | Finance |
Mount Sinai Genomics, Inc.
Mount Sinai Genomics, Inc. Medical/Nursing ServicesHealth Services Mount Sinai Genomics, Inc. operates online predictive health analysis platform for diagnosis, treatment and prevention of diseases. It offers Centrellis which analyzes and interprets extensive information about known inherited diseases, including related mutations, frequency across populations, and the penetrance and expressivity of genetic changes. The company was founded by Eric Schadt and is headquartered in Stamford, CT. | Health Services |
